A detailed history of D. E. Shaw & Co., Inc. transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 80,548 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80,548
Holding current value
$0
% of portfolio
0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
12,315 Added 18.05%
80,548 $0
Q2 2024

Aug 14, 2024

BUY
N/A
30,056 Added 78.73%
68,233 $0
Q1 2024

May 15, 2024

BUY
N/A
38,177 New
38,177 $0
Q1 2023

May 15, 2023

SELL
N/A
-19,396 Reduced 44.39%
24,302 $0
Q4 2022

Feb 14, 2023

BUY
N/A
14,409 Added 49.2%
43,698 $0
Q3 2022

Nov 14, 2022

SELL
N/A
-62,834 Reduced 68.21%
29,289 $155,000
Q2 2022

Aug 15, 2022

SELL
N/A
-95,199 Reduced 50.82%
92,123 $391,000
Q1 2022

May 16, 2022

SELL
N/A
-62,694 Reduced 25.08%
187,322 $658,000
Q4 2021

Feb 14, 2022

SELL
N/A
-564 Reduced 0.23%
250,016 $1.67 Million
Q3 2021

Nov 15, 2021

BUY
N/A
40,453 Added 19.25%
250,580 $2.5 Million
Q2 2021

Aug 16, 2021

BUY
N/A
4,714 Added 2.29%
210,127 $6.49 Million
Q1 2021

May 17, 2021

BUY
N/A
205,413 New
205,413 $8.96 Million

About ARS PHARMACEUTICALS, INC. COMM


  • Ticker SPRY
More about SPRY
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.